Meta facebook tracking pixel

Upcoming Workshops

For All Cancers

  1. Apr22
    Diverse Populations Participating in Decisions about Your Care
    Tags:
    black or african americandoctor-patient communicationhealth care disparitieshealth care professionalslgbtq+treatment
    Register

Past workshops

For All Cancers

    1. Diverse Populations Participating in Decisions About Your Care With Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      black or african americandoctor-patient communicationhealth care disparitieshealth care professionalslgbtq+treatment
    2. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      biomarkersblack or african americandoctor-patient communicationgenomicshealth care disparitiesside effectstreatmenthealth care professionalslgbtq+
    3. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      doctor-patient communicationhealth care disparitiesside effectstreatmentcoronavirusgenomicsbiomarkers
    4. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
      Tags:
      doctor-patient communication
    5. COVID-19, Omicron & Delta Variants, COVID-19 Vaccines & Booster Vaccines: Revised Guidelines for People Living with Cancer and Their Loved Ones
      Tags:
      coronavirusdoctor-patient communication
    6. How Health Care Disparities May Influence Your Cancer Treatment & Care
      Tags:
      doctor-patient communicationhealth care disparitiestreatmentblack or african american
    7. Cancer and Flu Shots
      Tags:
      adherencedoctor-patient communicationpost-treatment survivorshiptreatment
    8. Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      caregivingcopingdoctor-patient communicationside effectscare planningtreatment
    9. Communicating with Your Health Care Team After Treatment: Making the Most of Your VisitPart II of The Eighth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
      Tags:
      post-treatment survivorshipdoctor-patient communicationadvocacy
    10. The Importance of Communicating with Your Doctor About Follow-Up CarePart I of The Sixth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
      Tags:
      post-treatment survivorshipdoctor-patient communication

For Acute Lymphoblastic Leukemia

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Acute Myeloid Leukemia

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments
    2. For Caregivers: Informative Tips to Cope with Your Loved One’s Bladder CancerPart II of Life with Bladder Cancer
      Tags:
      bladder cancercaregivingdoctor-patient communication

For Brain Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
    2. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
    3. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Chronic Lymphocytic Leukemia

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Chronic Myelogenous Leukemia

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Cutaneous T-Cell Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Diffuse Large B-Cell Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Follicular Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Head and Neck Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Hodgkin Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Leukemia

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Mantle Cell Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Marginal Zone Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Metastatic Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
    2. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment

For Multiple Myeloma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Myeloproliferative Neoplasms

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Non-Hodgkin Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Ovarian Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Peripheral T-Cell Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Prostate Cancer

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Sarcoma

    1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
      Tags:
      brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Small Lymphocytic Lymphoma

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
    2. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment

For Triple Negative Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
    2. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
      Tags:
      breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.